Model Details(Unspecified organ) tumor
Model Name |
(Unspecified organ) tumor | Strain |
CD-1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
hematopoietic neoplasm • digestive system neoplasm • hematopoietic tumor • lung tumor • urinary system neoplasm • skeletal system neoplasm • respiratory system neoplasm • reproductive system neoplasm • special senses neoplasm • lymphoreticular system neoplasm • respiratory tumor • cardiovascular system neoplasm • tumor • tumour • integumentary neoplasm • endocrine tumor • neoplasm • endocrine system neoplasm |
Strain Synonyms |
outbred CD-1 • Swiss CD-1® • CD1 nontransgenic • Charles River CD-1 • Swiss CD-1 • Crl:CD-1®(ICR) • outbred CD1 • (Swiss) CD-1 • CD1 • Crl:CD-1(ICR)BR • ICR Crj:CD-1 • random-bred Crl:CD-1(ICR)BR • CD-1 outbred • Crl:CD-1 (ICR) BR • Crj:CD-1(ICR) • ICR(CD-1) • Crl: CD-1 (ICR) BR • ICR |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| (Unspecified organ) | Male |
1.0% (7 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Male |
21.8% (158 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Male |
17.5% (127 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Male |
0.1% (1 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Male |
2.5% (18 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Male |
0% (0 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Male |
1.5% (11 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Male |
6.9% (50 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Male |
2.9% (21 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Male |
0.3% (2 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Male |
54.5% (395 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Female |
2.2% (16 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Female |
13.9% (101 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Female |
3.3% (24 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Female |
0.4% (3 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Female |
10.2% (74 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Female |
0.4% (3 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Female |
2.5% (18 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Female |
16.4% (119 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Female |
1.7% (12 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Female |
2.8% (20 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Female |
53.5% (388 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| (Unspecified organ) | Female |
35.5% (11 of 31 mice) |
1 year |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Female |
43.5% (10 of 23 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Female |
38.9% (21 of 54 mice) |
1-2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Male |
16.1% (5 of 31 mice) |
1 year |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Male |
33.3% (7 of 21 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Male |
23.1% (12 of 52 mice) |
1-2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Male |
0.07% (1 of 1453 mice) |
up to 10 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| (Unspecified organ) | Male |
0.21% (3 of 1453 mice) |
up to 20 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| (Unspecified organ) | Male |
0.34% (5 of 1453 mice) |
up to 30 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| (Unspecified organ) | Male |
0.83% (12 of 1453 mice) |
up to 40 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| (Unspecified organ) | Male |
1.86% (27 of 1453 mice) |
up to 50 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| (Unspecified organ) | Female |
0% (0 of 1453 mice) |
up to 20 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| (Unspecified organ) | Female |
0.48% (7 of 1453 mice) |
up to 30 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| (Unspecified organ) | Female |
1.31% (19 of 1453 mice) |
up to 40 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| (Unspecified organ) | Female |
1.93% (28 of 1453 mice) |
up to 50 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |